WHO urges Ebola vaccine testing in Congo
The World Health Organization recommends prioritizing the use of the "EvoliVax" vaccine within a randomized clinical trial to combat the Ebola outbreak in the Democratic Republic of the Congo, especially since it is the only licensed vaccine against Zaire Ebola virus. Preliminary studies on animals have shown the vaccine's ability to provide cross-protection, but its effectiveness against the Bundibugyo virus still needs to be confirmed. The organization emphasized the importance of using the vaccine to immunize contacts of infected individuals, while continuing to develop a vaccine specifically targeted for this virus in the long term.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)